Predictive and Prognostic Biomarkers of Targeted Agents and Modern Immunotherapy in Renal Cell Carcinoma: Table 1

ESMO Open - United Kingdom
doi 10.1136/esmoopen-2015-000013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Long Non‑coding RNAs as Prognostic Biomarkers in Papillary Renal Cell Carcinoma

Oncology Letters
Cancer ResearchOncology
2019English

Review of Emerging Biomarkers in Head and Neck Squamous Cell Carcinoma in the Era of Immunotherapy and Targeted Therapy

Head and Neck
Otorhinolaryngology
2019English

Prognostic and Predictive Epigenetic Biomarkers in Oncology

Molecular Diagnosis and Therapy
MedicineMolecular MedicineGeneticsPharmacology
2018English

Role of Cytokine Therapy for Renal Cell Carcinoma in the Era of Targeted Agents

Current Oncology
Oncology
2009English

Prognostic and Predictive Biomarkers in Oesophagogastric Cancer

English

Successes and Limitations of Targeted Therapies in Renal Cell Carcinoma

Progress in Tumor Research
Cancer ResearchOncology
2014English

Letter: Programmed Cell Death Protein-1-Targeted Immunotherapy for Advanced Hepatocellular Carcinoma

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Targeted Therapy for Renal Cell Carcinoma

2011English

Targeted Therapy and Immunotherapy: Emerging Biomarkers in Metastatic Melanoma

Pigment Cell and Melanoma Research
BiochemistryDermatologyOncologyGeneticsMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy